Product Images Metformin Hydrochloride

The table shows the summary of mean percent changes from Baseline in major lipid variables at the final visit of a 24-week study. The study involved patients on Metformin Hydrochloride Tablets Extended Release of different doses once or twice a day. The changes indicate the percentages of change from baseline for different lipid variables, such as total cholesterol, total triglycerides, LDL-cholesterol, and HDL-cholesterol. Patients on different doses of the medication experienced varying changes from baseline during the course of the study.*

The given text shows a table that displays the mean changes in HbAs, Fasting Plasma Glucose, and Body Weight at Week 12 and the final visit of a 24-week study. The study compares the changes observed in patients who were given either Metformin Hydrochloride 500mg twice daily, Metformin Hydrochloride 1000mg once daily or Metformin Hydrochloride 1500mg once daily. The table displays the baseline, changes at 12 weeks and the final visit, 95% confidence intervals, and the number of patients (n) for each dosage. There is not enough information to determine the purpose or findings of the study.*